Home » Topics » BioWorld Science

BioWorld Science
RSS

Sunshine Lake Pharma, Dongguan Hec New Drug Research and Development patent RORgammaT antagonists

July 26, 2021

Targeting TYMP as potential new therapeutic strategy against COVID-19

July 26, 2021

Enteric HDL shown to prevent liver injury via portal vein

July 26, 2021

Deep intronic F9 gene variants linked to hemophilia B

July 26, 2021

ECM1a isoform plays a tumorigenic role and confers cancer cell cisplatin resistance

July 26, 2021

Progress in the search for opioid multitarget ligands for persistent pain relief

July 26, 2021

New phase II trial evaluates BDB-001 for PD-(L)1 refractory solid tumors

July 26, 2021

NKMAX studies SNK-01 with chemotherapy and cetuximab in advanced NSCLC

July 26, 2021

ExCellThera initiates phase I study of ECT-001-CB in sickle cell disease

July 23, 2021

Alzamend reports toxicology results for AL-002 in transgenic mouse model of Alzheimer's disease

July 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...